abstract |
The present invention is the reliability of 4- [17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-diene-11β-yl] benzaldehyde (E) -oxime (asoprisnyl) on pilot and manufacturing scale. And a reproducible manufacturing method. Asoprisnil produced in this way is characterized by very good physical stability and is therefore particularly suitable for the preparation of solid pharmaceutical formulations (tablets, coated tablets, etc.). |